Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Jeremy Tomlinson

Jeremy is Professor of Metabolic Endocrinology and consultant endocrinologist based in the Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford. He graduated from the University of Oxford Medical School, having previously completed his undergraduate degree at the University of Cambridge. He embarked upon a career in Diabetes & Endocrinology and secured an MRC Clinical Training Fellowship and obtained his PhD from University of Birmingham studying steroid metabolism and human obesity in 2003. Subsequently he obtained clinician scientist and senior fellowships from the Wellcome Trust and MRC. His research investigates the pathogenesis of human metabolic disease, including non-alcoholic fatty liver disease. His work explores the role of steroid hormones and bile acids in the development of hepatocellular cancer (HCC). Within DeLIVER Jeremy will be assessing novel urine biomarker tests as a strategy for the early detection of HCC.